KCM

Knoll Capital Management Portfolio holdings

AUM $141M
This Quarter Return
+65.96%
1 Year Return
+51.8%
3 Year Return
+256.4%
5 Year Return
+482.18%
10 Year Return
+5,137.57%
AUM
$57M
AUM Growth
+$57M
Cap. Flow
-$268M
Cap. Flow %
-469.45%
Top 10 Hldgs %
91.01%
Holding
23
New
1
Increased
Reduced
2
Closed
5
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CRBP icon
1
Corbus Pharmaceuticals
CRBP
$115M
$16.7M 29.31% 2,563,925
ABEO icon
2
Abeona Therapeutics
ABEO
$350M
$8.04M 14.09% 1,359,767
TOVX icon
3
Theriva Biologics
TOVX
$3.94M
$6.61M 11.59% 3,734,149
NTBL
4
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$4.41M 7.73% 860,605
CEMP
5
DELISTED
Cempra, Inc.
CEMP
$4.32M 7.57% 180,800
ADXS
6
DELISTED
Advaxis, Inc.
ADXS
$2.86M 5.01% 275,000
ARCT icon
7
Arcturus Therapeutics
ARCT
$462M
$2.8M 4.91% 1,115,315
VNRX icon
8
VolitionRX
VNRX
$74.2M
$2.58M 4.52% 461,538
AMPE
9
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$2.08M 3.65% 2,738,322 -500,000 -15% -$380K
LUMO
10
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$1.5M 2.64% 102,437
ALDX icon
11
Aldeyra Therapeutics
ALDX
$351M
$1.04M 1.82% 135,800
KERX
12
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$1.03M 1.81% 200,000
QLGN icon
13
Qualigen Therapeutics
QLGN
$3.03M
$869K 1.52% +526,903 New +$869K
ADXSW
14
DELISTED
Advaxis, Inc. Warrants
ADXSW
$750K 1.32% 112,500
NBSE
15
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$568K 1% 205,000
ENLV icon
16
Enlivex Therapeutics
ENLV
$25M
$424K 0.74% 250,970
LSTA icon
17
Lisata Therapeutics
LSTA
$19.9M
$266K 0.47% 55,781 -500,000 -90% -$2.38M
CSBR icon
18
Champions Oncology
CSBR
$93.8M
$184K 0.32% 111,111
EVOK icon
19
Evoke Pharma
EVOK
$8.49M
-55,660 Closed -$381K
GLMD icon
20
Galmed Pharmaceuticals
GLMD
$6.96M
-49,947 Closed -$224K
APTO
21
DELISTED
Aptose Biosciences, Inc.
APTO
-11,933 Closed -$29K
ZSAN
22
DELISTED
Zosano Pharma Corporation
ZSAN
-11,195 Closed -$15K
MDVN
23
DELISTED
MEDIVATION, INC.
MDVN
-4,397,838 Closed -$265M